Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-27

FDA Approved: LEVETIRACETAM — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a generic formulation of levetiracetam under an original application by Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)